Actively Recruiting
Study of an AI Pharmacy Chatbot to Support Patients and Caregivers in Hong Kong with Medication for Hyperglycaemia, Hypertension, and Hyperlipidaemia
Led by The University of Hong Kong · Updated on 2025-06-25
280
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
This research aims to develop and evaluate a conversational AI pharmacy chatbot to assist patients and caregivers in Hong Kong with questions about medications prescribed by the Hospital Authority HA. The study focuses on patients with hyperglycaemia, hypertension, or hyperlipidaemia and assesses how well the chatbot answers medication-related questions, its impact on medication adherence, knowledge, and consultation time with pharmacists. Participants will be randomly assigned to one of two groups an intervention group that uses the AI pharmacy chatbot through WhatsApp for 7 days, and a control group that does not use the chatbot. The chatbot provides instant, pharmacist-validated responses based on HA drug data and targets chronic conditions common in Hong Kong. The study includes a prototype phase with pharmacist feedback and a main phase involving at least 280 patients or caregivers. During the study, participants complete surveys before and after the intervention period, including usability questionnaires for the intervention group. Researchers will evaluate patient satisfaction, medication knowledge, adherence, response times, and pharmacist consultation duration. The study uses mixed qualitative and quantitative methods and runs from June 2025 through October 2026.
CONDITIONS
Brief Title
Developing an AI Pharmacy Chatbot for the Population of Hong Kong
Research Team
J
Joseph Wu, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
